1992
DOI: 10.1111/j.2042-3292.1992.tb01571.x
|View full text |Cite
|
Sign up to set email alerts
|

Tumour necrosis factor ‐ physiology and pathology

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

1995
1995
2004
2004

Publication Types

Select...
3

Relationship

2
1

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 27 publications
0
2
0
Order By: Relevance
“…There are few (if any) biochemical or haematological tests that will establish a general diagnosis of neoplasia, let alone a specific type; such a test would be a valuable clinical aid but would, in any case, itself be unlikely to confirm the type and location of the tumour. Recent advances in our understanding of neoplastic disease suggest that, at least in some cases, estimation of TNF-α, IL-1 and interferon-γ (May and Knottenbelt 1992;Cotchin et al 1998) may provide nonspecific information. Specific tumour markers are being identified in some human neoplastic diseases, such as prostate-specific antigen (PSA) in prostatic carcinoma and CA-15-3 in breast cancer, and this is clearly very helpful in these conditions.…”
Section: Fig 5: A) Disseminated Haemangiosarcoma Secondary Tumours Inmentioning
confidence: 99%
“…There are few (if any) biochemical or haematological tests that will establish a general diagnosis of neoplasia, let alone a specific type; such a test would be a valuable clinical aid but would, in any case, itself be unlikely to confirm the type and location of the tumour. Recent advances in our understanding of neoplastic disease suggest that, at least in some cases, estimation of TNF-α, IL-1 and interferon-γ (May and Knottenbelt 1992;Cotchin et al 1998) may provide nonspecific information. Specific tumour markers are being identified in some human neoplastic diseases, such as prostate-specific antigen (PSA) in prostatic carcinoma and CA-15-3 in breast cancer, and this is clearly very helpful in these conditions.…”
Section: Fig 5: A) Disseminated Haemangiosarcoma Secondary Tumours Inmentioning
confidence: 99%
“…Tumour necrosis factor is best known for its role in endotoxaemia and systemic infections. Endotoxins stimulate cells of monocyte/macrophage lineage to produce various inflammatory mediators and some of these act on other cells to produce the full spectrum of pathology associated with endotoxaemia and septicaemia (May and Knottenbelt 1992;Moms 1992). Tumour necrosis factor, with interleukin 1, interleukin 6 and gamma interferon, is one of the endogenous pyrogens, producing pyrexia associated with infection by resetting the body's thermal set-point.…”
Section: Equine Veterinary Journalmentioning
confidence: 99%